Literature DB >> 24395204

Facial affect perception and mentalizing abilities in female patients with persistent somatoform pain disorder.

M Schönenberg1, L Mares, R Smolka, A Jusyte, S Zipfel, M Hautzinger.   

Abstract

BACKGROUND: Numerous studies have demonstrated a robust link between alexithymic traits and somatic complaints in patients suffering from psychosomatic disorders, while less is known about disease-related impairments in the processing of affective social information. Deficits in emotion recognition can lead to misinterpretations of social signals and induce distress in interpersonal interactions. This, in turn, might contribute to somatoform symptomatology in affected individuals. The aim of the present study was to investigate basal facial affect recognition as well as higher-order cognitive mind-reading skills in order to further clarify the association between alexithymia and the processing of social affective information in a homogenous sample of patients suffering from somatoform pain.
METHODS: We employed a series of animated morph clips that gradually displayed the onset and development of the six basic emotional expressions to investigate facial affect perception in a female sample of patients diagnosed with persistent somatoform pain disorder (PSPD) and matched healthy controls. In addition, all participants were presented with the Movie for the Assessment of Social Cognition to explore mind-reading abilities.
RESULTS: Specifically impaired mentalizing skills and increased alexithymic traits were observed in PSPD, while emotional facial expression recognition appeared to be intact in these patients.
CONCLUSIONS: PSPD subjects tend to overattribute inappropriate affective states to others, which could be the consequence of the inability to adequately experience and express their own emotional reactions. This cognitive bias might lead to the experience of poor psychosocial functioning and has the potential to negatively impact the course and outcome of this psychopathology.
© 2014 European Pain Federation - EFIC®

Entities:  

Mesh:

Year:  2014        PMID: 24395204     DOI: 10.1002/j.1532-2149.2013.00440.x

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  7 in total

1.  Altered Spontaneous Activity in Patients with Persistent Somatoform Pain Disorder Revealed by Regional Homogeneity.

Authors:  Tianming Huang; Zhiyong Zhao; Chao Yan; Jing Lu; Xuzhou Li; Chaozheng Tang; Mingxia Fan; Yanli Luo
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

2.  High Rejection Sensitivity in Patients With Somatoform Pain Disorder.

Authors:  Yeliz Nacak; Eva Morawa; Yesim Erim
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

3.  Altered resting-state intra- and inter- network functional connectivity in patients with persistent somatoform pain disorder.

Authors:  Zhiyong Zhao; Tianming Huang; Chaozheng Tang; Kaiji Ni; Xiandi Pan; Chao Yan; Xiaoduo Fan; Dongrong Xu; Yanli Luo
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

4.  To know or not to know? Mentalization as protection from somatic complaints.

Authors:  Sergi Ballespí; Jaume Vives; Naida Alonso; Carla Sharp; María Salvadora Ramírez; Peter Fonagy; Neus Barrantes-Vidal
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

5.  Emotion regulation in patients with somatic symptom and related disorders: A systematic review.

Authors:  Zeynep Emine Okur Güney; Heribert Sattel; Michael Witthöft; Peter Henningsen
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

6.  Investigation of facial emotion recognition, alexithymia, and levels of anxiety and depression in patients with somatic symptoms and related disorders.

Authors:  Ahmet Öztürk; Alperen Kiliç; Erdem Deveci; İsmet Kirpinar
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-29       Impact factor: 2.570

7.  Processing of Emotional Faces in Patients with Chronic Pain Disorder: An Eye-Tracking Study.

Authors:  Katrin Elisabeth Giel; Sarah Paganini; Irena Schank; Paul Enck; Stephan Zipfel; Florian Junne
Journal:  Front Psychiatry       Date:  2018-03-05       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.